Refractory Central Nervous System Neoplasm
1 clinical trials · Condition
◉ Watch Refractory Central Nervous System Neoplasm
| Record | Firm | Date |
|---|---|---|
| Talazoparib and Temozolomide in Treating Younger Patients With Refractory or Recurrent Malignancies (NCT02116777) | National Cancer Institute (NCI) | 2014-05-16 |
Track Refractory Central Nervous System Neoplasm automatically
Every clearance here is in the API, with alerts when new ones post.